Navigation Links
Faulty Dosing Device Prompts Recall of Infants' Tylenol
Date:2/17/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 17 (HealthDay News) -- A potentially faulty dosing system on bottles of Infants' Tylenol has prompted McNeil Consumer Healthcare, a division of Johnson & Johnson, to recall all of the product.

The voluntary recall comes in response to some consumer complaints about the product's so-called SimpleMeasure dosing system, which dispenses measured doses of the medication.

The system includes a dosing syringe that an adult inserts into the cover at the top of the bottle. It's supposed to limit the amount of Tylenol that can be delivered in a single dose, according to the company.

In some cases, inserting the syringe pushed this "flow restrictor" into the bottle.

"Parents can continue to use the product as long as the flow restrictor is in place," Johnson & Johnson spokeswoman Bonnie Jacobs said. "If the flow restrictor does push into the bottle, then they should stop using it and contact us."

According to the company, there have been no adverse events reported due to the problem, "and the risk of a serious adverse medical event is remote."

Jacobs said she didn't know when Infants' Tylenol would be available again. "We're conducting a full review to determine why it's not performing as expected. We are looking at different options," she said.

The recall affects only Infants' Tylenol. Children's Tylenol, which is for use by children 2 years of age and older, remains on the market, Jacobs said.

More information

For more information, visit Johnson & Johnson.

SOURCE: Bonnie Jacobs, spokeswoman, Johnson & Johnson


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Journal Retracts Faulty Chronic Fatigue Study
2. Autism Tests for Preemies May Be Faulty, Study Suggests
3. Faulty off-switch stops children with ADHD from concentrating
4. Drug Targets Faulty Process That Drives Cystic Fibrosis
5. Web Site for Hospital Comparisons Is Faulty: Study
6. Faulty gene stops cell antennae from transmitting
7. Variation in make-up of generic epilepsy drugs can lead to dosing problems
8. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
9. Lengthening dosing schedule of HPV vaccine may provide effective option for expanding use of vaccine
10. Confusion Over Drug Dosing Common for Seniors
11. Cough Syrup Might Help With Dosing of Breast Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Faulty Dosing Device Prompts Recall of Infants' Tylenol
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: